Page 9 - Haematologica-5
P. 9
Table of Contents
Volume 103, Issue 5: May 2018
Cover Figure
haematologica Journal of the European Hematology Association
Published by the Ferrata Storti Foundation
Cluster of osteoblasts with eccentric round to oval nuclei and abundant blue, mottled cytoplasm. Courtesy of Prof. Rosangela Invernizzi.
Editorials
747 (Auto-)immune signature in aplastic anemia Antonio M. Risitano
749 Hematopoietic stem cell mobilization with plerixafor in sickle cell disease Matthew M. Hsieh and John F. Tisdale
751 Age-related clonal hematopoiesis and monoclonal B-cell lymphocytosis / chronic lymphocytic leukemia: a new association? Adalgisa Condoluci and Davide Rossi
Perspectives
753 Denosumab for bone lesions in multiple myeloma – what is its value? Daniel A. Goldstein
755 Osteoprotective medication in the era of novel agents: a European perspective on values, risks and future solutions Monika Engelhardt
Articles
Bone Marrow Failure
759 Deep sequencing and flow cytometric characterization of expanded effector memory CD8+CD57+ T cells frequently reveals T-cell receptor Vβ oligoclonality and CDR3 homology in acquired aplastic anemia
Valentina Giudice et al.
Red Cell Biology & its Disorders
770 Safety and efficacy of plerixafor dose escalation for the mobilization of CD34+ hematopoietic progenitor cells in patients with sickle cell disease: interim results
Farid Boulad et al.
778 Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion Chantal Lagresle-Peyrou et al.
787 RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice Alfia Khaibullina et al.
Myeloproliferative Disorders
798 The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis
Mathias Schneeweiss et al.
Acute Myeloid Leukemia
810 Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival Steven M. Kornblau et al.
822 Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group Yann Ferret et al.
Haematologica 2018; vol. 103 no. 5 - May 2018 http://www.haematologica.org/
